Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.78 |
| ▸ | LMNA | P02545 | 1/20 | 0.78 |
| ▸ | GFER | P55789 | 1/20 | 0.73 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.73 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.73 |
| ▸ | KDM1A | O60341 | 1/20 | 0.72 |
| ▸ | RCOR1 | Q9UKL0 | 1/20 | 0.72 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.71 |
| ▸ | MEN1 | O00255 | 1/20 | 0.71 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.69 |
| ▸ | TSHR | P16473 | 2/20 | 0.69 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.66 |
| ▸ | TP53 | P04637 | 1/20 | 0.62 |
| ▸ | CTRB1 | P17538 | 1/20 | 0.59 |
| ▸ | POLB | P06746 | 1/20 | 0.58 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.58 |
| ▸ | HTT | P42858 | 1/20 | 0.58 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7265745 | 0.92 | KDM4E (0.78) | KDM4ELMNAGFERHSD17B10NPSR1 | |
| SCHEMBL7265734 | 0.92 | KDM4E (0.78) | KDM4ELMNAGFERHSD17B10NPSR1 | |
| SCHEMBL13388185 | 0.91 | KDM4E (0.77) | KDM4ELMNAGFERHSD17B10NPSR1 | |
| SCHEMBL4397563 | 0.90 | KDM4E (0.76) | KDM4ELMNAGFERHSD17B10NPSR1 | |
| SCHEMBL13588884 | 0.90 | KDM4E (0.76) | KDM4ELMNAGFERHSD17B10NPSR1 | |
| SCHEMBL4387714 | 0.90 | KDM4E (0.76) | KDM4ELMNAGFERHSD17B10NPSR1 | |
| SCHEMBL13588907 | 0.90 | KDM4E (0.76) | KDM4ELMNAGFERHSD17B10NPSR1 | |
| SCHEMBL4382112 | 0.89 | KDM4E (0.74) | KDM4ELMNAGFERHSD17B10NPSR1 | |
| SCHEMBL12829387 | 0.89 | KDM4E (0.74) | KDM4ELMNAGFERHSD17B10NPSR1 | |
| SCHEMBL4388740 | 0.89 | KDM4E (0.74) | KDM4ELMNAGFERHSD17B10NPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8815928-B2 | Hepatitis C virus inhibitors | ENANTA PHARMACEUTICALS, INC. (US) | 2014-08-26 | — | — | US | disclosed |
| US-20110070197-A1 | HEPATITIS C VIRUS INHIBITORS | ENANTA PHARMACEUTICALS, INC. | 2011-03-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110070197-A1 | HEPATITIS C VIRUS INHIBITORS | HAVCR2, EIF2AK2, SLC10A1 | KDM4E 1139/4885LMNA 2791/4885GFER 1965/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.